Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VRx: Randomized Controlled Trial to Evaluate the Impact of Virtual Reality Therapy on Behavioural and Psychological Symptoms and Quality of Life of Individuals With Dementia Admitted to an Acute Care Hospital

NCT03941119 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03941119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03941119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VRx: Randomized Controlled Trial to Evaluate the Impact of Virtual Reality Therapy on Behavioural and Psychological Symptoms and Quality of Life of Individuals With Dementia Admitted to an Acute Care Hospital
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Terminated
Start date
May 6, 2019
Completion date
March 16, 2020
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium superimposed on dementia, dementia